Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,379 | 27,136 | 11,701 | 27,492 | 13,136 |
| Marketable Securities | 1,062 | 1,093 | 8,718 | 470 | 912 |
| Receivables | 5,351 | 5,546 | 387 | 532 | N/A |
| Other current assets | 1,899 | 1,899 | 1,899 | 0 | 0 |
| TOTAL | $26,392 | $36,983 | $25,819 | $30,844 | $15,931 |
| Non-Current Assets | |||||
| PPE Net | 288 | 241 | 307 | 454 | 523 |
| Other Non-Current Assets | 4,197 | 4,988 | 5,518 | 9,409 | 5,800 |
| TOTAL | $4,485 | $5,229 | $5,825 | $9,863 | $6,323 |
| Total Assets | $30,877 | $42,212 | $31,644 | $40,707 | $22,254 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,458 | 2,416 | 3,374 |
| Accounts payable and accrued liabilities | 4,330 | 4,637 | 2,348 | 3,627 | 4,319 |
| Accrued Expenses | 1,499 | 1,611 | 1,871 | 1,518 | 4,230 |
| Other current liabilities | N/A | 5,335 | 7,816 | 9,579 | N/A |
| TOTAL | $7,391 | $13,494 | $15,524 | $19,254 | $15,498 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 190 | 190 | N/A |
| Other Non-Current Liabilities | 1,878 | 2,286 | 2,684 | 3,104 | 176 |
| TOTAL | $1,878 | $2,286 | $2,874 | $3,294 | $176 |
| Total Liabilities | $9,269 | $15,780 | $18,398 | $22,548 | $15,674 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,046 | 3,252 | 2,622 | 2,559 | 2,509 |
| Common Shares | 3 | 3 | 78 | 76 | 62 |
| Retained earnings | -373,644 | -368,466 | -370,051 | -362,603 | -354,121 |
| Other shareholders' equity | 0 | 0 | 1 | 0 | 0 |
| TOTAL | $21,608 | $26,432 | $13,246 | $18,159 | $6,580 |
| Total Liabilities And Equity | $30,877 | $42,212 | $31,644 | $40,707 | $22,254 |